Quantification of Coronary Atherosclerosis in the Assessment of Coronary Artery Disease

Sang-Eun Lee1,2, Ji Min Sung1,2, Asim Rizvi3

  • 1Division of Cardiology, Severance Cardiovascular Hospital (H.-J.C., S.-E.L., J.M.S.).

Insights

Quantifying coronary plaque burden (PB) using computed tomography angiography improves prediction of coronary artery disease progression. Direct PB measurement offers better risk stratification than traditional stenosis assessment alone.

Area of Science:

  • Cardiovascular Imaging
  • Interventional Cardiology
  • Radiology

Background:

  • Traditional diagnosis of coronary artery disease relies on diameter stenosis ≥50%.
  • The predictive value of direct plaque burden (PB) and plaque characteristics for rapid progression is under-explored.
  • Coronary computed tomography angiography (CCTA) enables quantitative plaque assessment.

Purpose of the Study:

  • To evaluate if direct quantification of PB and plaque characteristics by CCTA adds value in predicting rapid plaque progression.
  • To compare the predictive performance of quantitative PB analysis versus conventional angiography for coronary artery disease (CAD).
  • To assess the utility of PB quantification for improving CAD risk stratification.

Main Methods:

  • Prospective observational registry with 1345 patients from 13 centers across 7 countries.
  • Repeated CCTA performed >2 years apart for quantitative analysis of PB and annual change (△PB/y).
  • Conventional angiographic analysis included stenosis ≥50%, vessel involvement, segment involvement score, and high-risk plaque features.

Main Results:

  • Rapid progressors (≥median △PB/y) were older, more often male, and had more risk factors.
  • Baseline PB improved prediction of rapid progression, further enhanced by high-risk plaque features (P<0.001).
  • Combined baseline PB and △PB/y provided the best prediction of adverse outcomes (C-statistic 0.763, P<0.001).

Conclusions:

  • Direct quantification of atherosclerotic PB by CCTA offers incremental value for risk stratification in coronary artery disease.
  • Quantitative plaque assessment may enhance the prediction of disease progression and adverse clinical outcomes.
  • Integrating PB quantification into routine assessment could improve patient management strategies for CAD.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
500
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
289
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
399
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Coronary Circulation01:21

Coronary Circulation

The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.4K